Millennium Management
ELDN icon

Millennium Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Millennium Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,788
Closed -$35.9K – 5877
2025
Q4 		$35.9K Buy
+23,788
New +$56.5K ﹤0.01% 5771
2025
Q3 		– Sell
-171,669
Closed -$465K – 6120
2025
Q2 		$465K Sell
171,669
-639,207
-79% -$1.92M ﹤0.01% 4954
2025
Q1 		$2.75M Buy
810,876
+692,015
+582% +$2.85M ﹤0.01% 3470
2024
Q4 		$490K Buy
+118,861
New +$469K ﹤0.01% 4768
2024
Q2 		– Sell
-13,875
Closed -$28.6K – 6029
2024
Q1 		$28.6K Sell
13,875
-8,992
-39% -$16K ﹤0.01% 5772
2023
Q4 		$41.2K Sell
22,867
-4,283
-16% -$5.95K ﹤0.01% 5511
2023
Q3 		$37.2K Sell
27,150
-15,852
-37% -$21.2K ﹤0.01% 5540
2023
Q2 		$58.9K Buy
43,002
+30,397
+241% +$63.4K ﹤0.01% 5442
2023
Q1 		$30K Buy
+12,605
New +$33.8K ﹤0.01% 5768
2022
Q2 		– Sell
-11,951
Closed -$47K – 7087
2022
Q1 		$47K Sell
11,951
-24,291
-67% -$94.2K ﹤0.01% 6411
2021
Q4 		$160K Buy
36,242
+25,693
+244% +$130K ﹤0.01% 6048
2021
Q3 		$65K Sell
10,549
-7,444
-41% -$52K ﹤0.01% 6535
2021
Q2 		$142K Buy
17,993
+3,405
+23% +$32.1K ﹤0.01% 6137
2021
Q1 		$156K Buy
+14,588
New +$220K ﹤0.01% 5576
2017
Q4 		– Sell
-564
Closed -$53K – 3851
2017
Q3 		$53K Buy
+564
New +$46.8K ﹤0.01% 3408
2017
Q1 		– Sell
-142
Closed -$22K – 3561
2016
Q4 		$22K Buy
142
+64
+82% +$12.3K ﹤0.01% 3277
2016
Q3 		$19K Buy
+78
New +$28.5K ﹤0.01% 3215
2016
Q2 		– Sell
-91
Closed -$82K – 3264
2016
Q1 		$82K Sell
91
-163
-64% -$160K ﹤0.01% 3109
2015
Q4 		$359K Buy
254
+163
+179% +$284K ﹤0.01% 2820
2015
Q3 		$153K Buy
+91
New +$187K ﹤0.01% 3190
2014
Q4 		– Sell
-327
Closed -$802K – 3995
2014
Q3 		$802K Buy
+327
New +$929K ﹤0.01% 2452

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Millennium Management's ELDN Position: Q1 2026 in Review

Millennium Management sold out of Eledon Pharmaceuticals (ELDN) in Q1 2026, closing a stake of 23,788 shares — an estimated $35.9K sold.

Millennium Management first reported a position in ELDN in Q3 2014 and held it in 21 quarters. The position peaked at $2.75M in Q1 2025. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Millennium Management reported no remaining Eledon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 23,788 Eledon Pharmaceuticals shares in Q1 2026, an estimated $35.9K.
  • Millennium Management first reported a position in Eledon Pharmaceuticals in Q3 2014 and held it in 21 quarters.
  • Millennium Management's Eledon Pharmaceuticals position peaked at $2.75M in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.